Authors: FINEMAN M KODA J KOLTERMAN O

Citation: M. Fineman et al., SUBCUTANEOUS ADMINISTRATION OF A HUMAN AMYLIN ANALOG SUPPRESSES POSTPRANDIAL PLASMA-GLUCAGON CONCENTRATIONS IN TYPE-1 DIABETIC-PATIENTS, Diabetes, 47, 1998, pp. 346-346

Authors: WAREHAM N WILLIAMS D FINEMAN M KODA J ANDERSON S DAY N HALES CN

Citation: N. Wareham et al., FASTING TOTAL PLASMA AMYLIN CONCENTRATION PREDICTS DETERIORATION IN GLUCOSE-TOLERANCE OVER 4.5 YEARS, Diabetes, 46, 1997, pp. 78-78

Authors: FINEMAN M KOLTERMAN O THOMPSON R KODA J

Citation: M. Fineman et al., THE HUMAN AMYLIN ANALOG PRAMLINTIDE INHIBITED GLUCAGON-SECRETION IN TYPE-I DIABETIC SUBJECTS, Diabetes, 46, 1997, pp. 117-117

Authors: KODA J FINEMAN M PERCY A BLASE E LILLIOJA S

Citation: J. Koda et al., USE OF A NEW 2-SITE IMMUNOASSAY FOR AMYLIN TO CHARACTERIZE AMYLIN HORMONE RESPONSE IN PIMA-INDIANS, Diabetologia, 36, 1993, pp. 10000137-10000137